47 results on '"Syrykh, Charlotte"'
Search Results
2. Bias reduction using combined stain normalization and augmentation for AI-based classification of histological images
3. Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC
4. A challenging case of aggressive composite hemangioendothelioma with neuroendocrine differentiation and PTBP1::MAML2 fusion
5. Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French Lymphopath network survey
6. Integrated spatial and multimodal single‐cell transcriptomics reveal patient‐dependent cell heterogeneity in splenic marginal zone lymphoma.
7. Activated PI3 Kinase Delta Syndrome Revealed by Vasculitis and Disseminated Toxoplasmosis
8. Molecular diagnosis of T-cell lymphoma: a correlative study of PCR-based T-cell clonality assessment and targeted NGS
9. ALK-positive histiocytosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: a multitarget response under ibrutinib
10. IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia
11. BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases
12. Accurate diagnosis of lymphoma on whole-slide histopathology images using deep learning
13. Single-cell RNA sequencing of human non-hematopoietic bone marrow cells reveals a unique set of inter-species conserved biomarkers for native mesenchymal stromal cells
14. Supplementary Table S3 from Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid Leukemia
15. Using a contextualized sensemaking model for interaction design: A case study of tumor contouring
16. Histoséminaire de la Société française de pathologie « apport des nouvelles techniques de biologie moléculaire dans le diagnostic des lymphomes : mythe ou réalité ? » - Pré-Test
17. Histoséminaire « apport des nouvelles techniques de biologie moléculaire dans le diagnostic des lymphomes : mythe ou réalité ? ». Cas no 5 & 6
18. Hyperplasie lymphoïde folliculaire induite par la prise de dasatinib, une entité à connaître
19. The ALK-OBS Trial: Results of a Multicenter Prospective Study Assessing the Prognostic Value of New Markers in Adults with ALK-Positive ALCL Treated By CHOEP: A Lysa Study
20. Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma
21. Phenotypic and Histological Distribution Analysis Identify Mast Cell Heterogeneity in Non-Small Cell Lung Cancer
22. “Accelerated phase” chronic lymphocytic leukemia: Still an intermediate risk disease in the era of targeted therapies
23. Current and Future Tools for Diagnosis of Kaposi’s Sarcoma
24. Resistance of B-Cell Lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in Transdifferentiation
25. High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B
26. Epstein–Barr Virus-Associated T- and NK-Cell Lymphoproliferative Diseases: A Review of Clinical and Pathological Features
27. Chronic myeloid leukemia revealed through focal bone lesions responding to imatinib: The bee's knees
28. Leucémie myéloïde chronique révélée par des lésions osseuses focales répondant à l’imatinib
29. Resistance of B-Cell Lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in Transdifferentiation.
30. Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma
31. ALK-positive histiocytosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: a multitarget response under ibrutinib
32. First case of classical Hodgkin‐like EBV ‐positive lymphoproliferative disorder under ruxolitinib therapy
33. Primary B-Cell lymphoma of the uterine cervix presenting with right ureter hydronephrosis: A case report
34. Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid Leukemia
35. Immunohistochemistry with anti-MAL antibody and RNAscope with MAL probes are complementary techniques for diagnosis of primary mediastinal large B-cell lymphoma
36. Exclusive B‐cell phenotype of primary prostatic lymphomas: a potential role of chronic prostatitis
37. Extracellular ATP and CD39 activate cAMP-mediated mitochondrial stress response to promote cytarabine resistance in acute myeloid leukemia
38. Immunohistochemistry with anti-MAL antibody and RNAscope with MAL probes are complementary techniques for diagnosis of primary mediastinal large B-cell lymphoma.
39. MYC Rearrangement Prediction from LYSA Whole Slide Images in Large B-cell Lymphoma: A Multi-centric Validation of Self-supervised Deep Learning Models
40. IGLV3-21R110mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia
41. Histoséminaire « Apport des nouvelles techniques de biologie moléculaire dans le diagnostic des lymphomes : mythe ou réalité? ». Cas n°5 & 6
42. First case of classical Hodgkin‐like EBV‐positive lymphoproliferative disorder under ruxolitinib therapy.
43. BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases.
44. [Histoseminar: "The contribution of new molecular biology techniques in the diagnosis of lymphoma: Myth or reality?". Cases No. 5 & 6].
45. [Dasatinib-induced follicular lymphoid hyperplasia, an entity to know].
46. Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC.
47. Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.